Page 49 - journal_12-3_Full

249

3,13 10. Braga ME, Leal PF, Carvalho JE, Meireles MA. Comparison
°àÕππÕπ
of yield, composition, and antioxidant activity of turmeric
À¡“¬‡Àμÿ
(Curcuma longa L.) extracts obtained using various
1. ¡’√“¬ß“π°“√«‘®—¬«à“¢¡‘Èπ™—π¡’ƒ∑∏‘Ï„π°“√ techniques. J Agric Food Chem. 2003;51(22):6604-11.
42 11. Kang HM, Son KH, Yang DC, Han DC, Kim JH, Baek NI,
√—°…“·º≈„π°√–‡æ“–Õ“À“√‰¥â ·μà¡’√“¬ß“π«à“°“√
Kwon BM. Inhibitory activity of diarylheptanoids on farnesyl
„™â¢¡‘Èπ™—πÀ√◊Õ “√‡§Õ√姑«¡‘π„π¢π“¥ Ÿß„π —μ«å protein transferase. Nat Prod Res. 2004;18(4):295-9.
12. Park SY, Kim DS. Discovery of natural products from
∑¥≈ÕßÕ“®∑”„À⇰‘¥·º≈„π°√–‡æ“–Õ“À“√‰¥â
Curcuma longa that protect cells from beta-amyloid insult:
43,44
‡™àπ°—π a drug discovery effort against Alzheimerûs disease. J Nat
Prod. 2002;65(9):1227-31.
2. §«√‡°Á∫¢¡‘Èπ™—π„π¿“™π–ªî¥ π‘∑ ªÑÕß°—π
13. §≥–Õπÿ°√√¡°“√æ—≤π“∫—≠™’¬“À≈—°·Ààß™“μ‘ §≥–
· ß·≈–§«“¡™◊Èπ ·≈–„Àâπ”ÕÕ°¡“º÷Ëß≈¡„Àâ·Àâß∑ÿ° °√√¡°“√·Ààß™“μ‘¥â“π¬“. ∫—≠™’¬“À≈—°·Ààß™“μ‘ æ.». 2542
2
2-3 ‡¥◊Õπ (∫—≠™’¬“®“° ¡ÿπ‰æ√). æ‘¡æå§√—Èß∑’Ë 1. °√ÿ߇∑æœ:
‚√ßæ‘¡æå™ÿ¡πÿ¡ À°√≥å°“√‡°…μ√·Ààߪ√–‡∑»‰∑¬ ®”°—¥;
2543. Àπâ“ 16-23.
14. ∫ÿ…∫“ ª√–¿“ æß»å, Õÿ∑—¬ ‰™¬°≈“ß, »‘√‘¡“≈“
‡Õ° “√Õâ“ßÕ‘ß
ÿ«√√≥‚¿§‘π, §≥–∫√√≥“∏‘°“√. ·æ∑¬å»“ μ√å ߇§√“–Àå:
1. Thai Herbal Pharmacopoeia. Vol. I. Nonthaburi: Department ¿Ÿ¡‘ªí≠≠“∑“ß°“√·æ∑¬å·≈–¡√¥°∑“ß«√√≥°√√¡¢Õß
of Medical Sciences, Ministry of Public Health. 1995. p. ™“μ‘. °√ÿ߇∑æœ: ‚√ßæ‘¡æå§ÿ√ÿ ¿“≈“¥æ√â“«; 2542. Àπâ“ 381.
38-44. 15. Babu PS, Srinivasan K. Hypolipidemic action of curcumin,
2. WHO Monographs on Selected Medicinal Plants. Vol. I. the active principle of turmeric (Curcuma longa) in
Geneva: World Health Organization. 1999. p. 115-24. streptozotocin induced diabetic rats. Mol Cell Biochem.
3. ∂“∫—π«‘®—¬ ¡ÿπ‰æ√ °√¡«‘∑¬“»“ μ√å°“√·æ∑¬å 1997;166(1-2):169-75.
°√–∑√«ß “∏“√≥ ÿ¢. ¡“μ√∞“π ¡ÿπ‰æ√‰∑¬ ¢¡‘Èπ™—π. 16. Babu PS, Srinivasan K. Influence of dietary curcumin and
æ‘¡æå§√—Èß∑’Ë 1. °√ÿ߇∑æœ: ”π—°æ‘¡æå∫â“π «π»‘≈ªá; 2544. cholesterol on the progression of experimentally induced
Àπâ“ 23-26, 58, 59. diabetes in albino rat. Mol Cell Biochem. 1995;152(1):13-
4. à«π情»“ μ√åªÉ“‰¡â ”π—°«‘™“°“√ªÉ“‰¡â °√¡ªÉ“‰¡â. 21.
™◊ËÕæ√√≥‰¡â·Ààߪ√–‡∑»‰∑¬ ‡μÁ¡ ¡‘μ‘π—π∑πå. ©∫—∫ 17. Soni KB, Kuttan R. Effect of oral curcumin administration
·°â‰¢‡æ‘Ë¡‡μ‘¡. °√ÿ߇∑æœ: ∫√‘…—∑ ª√–™“™π ®”°—¥; 2544. on serum peroxides and cholesterol levels in human
Àπâ“ 160. volunteers. Indian J Physiol Pharmacol. 1992;36(4):275-5.
5. Burtt BL, Smith RM. Zingiberaceae. A revised handbook 18. Srinivasan K, Sambaiah K. The effect of spices on
to the Flora of Ceylon. Vol. 4. Rotterdam (Netherlands): cholesterol 7 alpha-hydroxylase activity and on serum and
AA Balkema. 1983. p. 499-501. hepatic cholesterol levels in the rat. Int J Vitam Nutr Res.
6. Wu D, Larsen K. Zingiberaceae. In: Wu ZY, Raven PH. 1991;61(4):364-9.
editors. Flora of China. Vol. 24. Beijing: Science Press. 19. Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Babu,
2005. p. 361. Vessby B. Effects of dietary phenolic compounds on
7. ™¬—πμå 摇™’¬√ ÿπ∑√, ·¡âπ¡“» ™«≈‘μ, «‘‡™’¬√ ®’√«ß å. §” tocopherol, cholesterol, and fatty acids in rats. Lipids.
Õ∏‘∫“¬μ”√“æ√–‚Õ ∂æ√–π“√“¬≥å ©∫—∫‡©≈‘¡æ√–‡°’¬√μ‘ 2000;35(4):427-35.
72 æ√√…“¡À“√“™“ 5 ∏—𫓧¡ æÿ∑∏»—°√“™ 2542. 20. Permpiphat U, Kieatyingungsulee N, Anulakanapakorn K,
æ‘¡æå§√—Èß∑’Ë 2. °√ÿ߇∑æœ: ”π—°æ‘¡æåÕ¡√‘π∑√å ·≈–¡Ÿ≈π‘∏‘ Jirajaringyavech W, Kittisiripornkul S, Chuthaputti A.
¿Ÿ¡‘ªí≠≠“; 2548. Àπâ“ 260-2. Pharmacological study of Curcuma longa. Symposium of
8. Evans WC. Trease and Evansû pharmacognosy. 14th ed. the Department of Medical Sciences; 1990 Dec 3-4;
London: WB Saunders Company Ltd; 1996. p. 438. Bangkok, Thailand.
9. Grainger NG, Wichtl M, editors. Herbal drugs and 21. Rumpel W. Zur pharmakolgie des divanillal cyclohexanon
phytopharmaceuticals. Stuttgart: CRC Press; 1994. p. 173-5. (DVC). Arch Pharm. 1954;287:350-2.